Bioceres Crop Solutions Corp. (NASDAQ: BIOX), a leading biotechnology company committed to transforming agriculture through climate-resilient and regenerative solutions, has announced significant updates to the composition of its Board of Directors. These changes, effective June 24, 2025, are designed to strengthen the Company’s leadership team as it enters a new phase of strategic execution and global expansion.
New Board Appointments Reflect Strategic and Financial Expertise
Bioceres will welcome two new members to its Board of Directors: Noah Kolatch and Scott Crocco. These appointments bring deep industry knowledge, investment acumen, and operational leadership to the boardroom at a critical time for the Company.
Noah Kolatch, a seasoned investment professional, currently serves as a Principal at Jasper Lake LLC, a family investment office that manages diversified portfolios across both public and private markets. His background includes a successful tenure as Partner at Solel Partners, a Boston-based investment firm focused on public equities and credit strategies. Mr. Kolatch holds a Bachelor of Arts degree in biochemistry from Columbia College, where he graduated summa cum laude. His investment philosophy and history of involvement with Bioceres — including supporting key growth initiatives such as the acquisition of Marrone Bio Innovations — position him as a highly strategic addition to the Board.
Scott Crocco brings over 30 years of executive experience in financial leadership and corporate transformation. Mr. Crocco served as Chief Financial Officer of Air Products & Chemicals, Inc. (NYSE: APD), where he was instrumental in leading large-scale restructuring and business portfolio realignment. He later held the CFO role at Imperial Dade, a leading private equity-backed distribution company. With a Bachelor of Science in Electrical Engineering from Bucknell University and an MBA from Cornell University, Mr. Crocco offers a powerful combination of technical insight, operational efficiency, and financial stewardship. His history at Air Products includes guiding the company through a period of sustained profitability, disciplined capital deployment, and global market expansion.
Honoring Departing Directors and Their Contributions
As part of this transition, Gloria Montaron Estrada and Keith McGovern will step down from their roles on the Board, effective the same date. Both have been integral to Bioceres’ recent history and its evolution into a publicly traded global agritech leader.
Gloria Montaron Estrada has been associated with Bioceres since 2019 and has played a pivotal role during a critical period of the Company’s growth. Initially joining as General Counsel, Estrada provided expert guidance on the Company’s legal and regulatory frameworks. She was instrumental in structuring and executing landmark transactions, including the acquisition of Rizobacter and Bioceres’ IPO. Her transition from executive leadership to Board service helped maintain strategic continuity and governance oversight as the Company matured.
Keith McGovern joined the Board in 2022 following Bioceres’ acquisition of Marrone Bio Innovations. As an advocate for sustainable farming practices and farmer-centric innovation, McGovern brought a valuable, grounded perspective to the Company’s strategic discussions. His background in the agricultural sector helped sharpen Bioceres’ operational execution and ensured alignment with the needs and realities of farmers on the ground.
Federico Trucco, CEO of Bioceres Crop Solutions, expressed deep appreciation for the outgoing directors and enthusiasm for the incoming ones:
“On behalf of our Board, our Company, and personally, I would like to express our deepest gratitude to Gloria and Keith. Gloria’s leadership, from legal counsel to Board member, has shaped our legal and strategic direction during major milestones like the Rizobacter acquisition and our IPO. Keith’s insights since the Marrone Bio acquisition have strengthened our operational discipline and kept us attuned to the voices of growers. As we move forward, I am thrilled to welcome Noah and Scott to our Board. Both bring immense talent and a shared commitment to our mission. Noah has been a steadfast supporter of our vision since our early public days, and Scott’s exceptional career at Air Products underscores his ability to create lasting shareholder value. Their expertise will be instrumental as we refine our strategy and continue to scale globally.”
Internal Leadership Transitions Within the Board
In addition to the external appointments and resignations, internal changes are also being made to further align the Company’s leadership structure with its operational and strategic priorities.
Enrique Lopez Lecube, currently serving as Bioceres’ Chief Financial Officer and a member of the Company’s senior management team, will rotate off the Board of Directors effective June 24, 2025. His departure from the Board is not a reflection of any diminished role at the Company; Mr. Lopez Lecube will continue in his CFO capacity, overseeing financial planning, capital markets, and investor relations.
Replacing him on the Board will be Milen Marinov, Bioceres’ Chief Commercial Officer. Marinov, who also serves as a member of the Company’s senior management team, will bring an invaluable commercial lens to the Board. His deep understanding of global markets, customer needs, and go-to-market strategies will help the Board maintain strong connectivity to business development efforts and market opportunities.
Governance Changes Tied to Financing Agreements
These Board changes were implemented in connection with amendments to two previously existing note purchase agreements, initially signed in August 2022. At that time, Bioceres issued secured guaranteed convertible notes to investors including Jasper Lake Ventures One LLC, Redwood Enhanced Income Corp., and Liminality Partners LP. Additionally, secured guaranteed notes were issued to Solel-Bioceres SPV, L.P.
The recently announced amendments were negotiated as part of the Company’s ongoing capital structure optimization strategy. The terms of the amendments — which were detailed in a Form 6-K filed with the U.S. Securities and Exchange Commission on June 18, 2025 — include governance provisions that align investor representation and board composition with the Company’s strategic needs. These changes ensure that the evolving shareholder base and management team are synchronized in their long-term vision for Bioceres’ growth and global footprint.
A full summary of the amendments, along with the official filing and associated exhibits, is available through the SEC’s EDGAR database under Bioceres Crop Solutions’ filings.
Positioning Bioceres for a Climate-Resilient Agricultural Future
As the global agricultural sector faces mounting challenges from climate change, soil degradation, and population growth, Bioceres is uniquely positioned to provide regenerative, science-backed solutions that enhance productivity and environmental sustainability. With these Board transitions, the Company reinforces its commitment to strategic governance, robust capital deployment, and stakeholder-aligned innovation.
These changes mark another step forward in Bioceres’ journey toward becoming a global leader in sustainable agriculture — not only by delivering high-impact technologies, but also by building the leadership structure required to guide its bold mission.
